Latest Regulatory News

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.

Silex Systems announces that its exclusive licensee, Global Laser Enrichment, has achieved a critical technology milestone for its laser uranium enrichment process, enabling plans for a new US enrichment facility to advance.

Fortescue Metals Group kicked off FY26 with record iron ore shipments and strengthened its decarbonisation strategy through new partnerships and a $2 billion Renminbi loan.

Insignia Financial reported a 3.1% rise in Funds Under Management and Administration to $340.5 billion, driven by strong net inflows into its Wrap platform and strategic enhancements to its MLC offerings. The company also completed a key custody transition and unveiled a refreshed MLC brand campaign.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

VRX Silica Limited has secured four binding offtake contracts for 410,000 tonnes per annum of silica sand from its Arrowsmith North project, representing nearly half of its initial production capacity and marking a significant commercial milestone.

St George Mining’s latest diamond drilling results at the Araxá Project confirm a significant westward extension of high-grade rare earth and niobium mineralisation, reinforcing the potential for a major resource upgrade.

E79 Gold Mines has reported outstanding high-grade copper and gold assay results from its Mountain Home Project in the Northern Territory, significantly expanding the known mineralised area and setting the stage for drilling in 2026.

Beacon Minerals has announced a robust Laterite Ore Reserve at its Iguana Deposit, projecting strong pre-tax cash flows and a streamlined 12-month mine life. The Pre-Feasibility Study underscores the project’s economic viability amid current gold prices.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Alcoa Corporation reported a $232 million net income in Q3 2025 despite significant restructuring costs, driven by increased alumina and aluminum production and strategic asset sales.